Fundz

Organon & Co. Announces Merger with Sun Pharmaceutical Industries Limited

PUBLIC · OGNOct 30, 2026

Acquiring Company

Organon

Acquired Company

Sun Pharmaceutical Industries Ltd

Jersey CityBiotechnologyHealth CareMedicalBiotechnologyHealth Care

Description

Organon & Co. has announced a pending merger with Sun Pharmaceutical Industries Limited. This strategic move aligns with Organon's commitment to enhancing women's health and expanding its product offerings. The merger reflects the companies' shared mission to provide innovative health solutions globally. Details concerning the transaction value and closing date were not disclosed in the current filing.

Who to call at Organon, and when

When Organon changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Organon raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Organon, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Organon. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Organon

Location

Jersey City, New Jersey, United States

About

Organon is a global healthcare company formed through a spin-off from Merck, (NYSE: MRK) known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. Organon has a portfolio of more than 60 medicines and products across a range of therapeutic areas. Led by the women’s health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products produce strong cash flows that will support investments in innovation and future growth opportunities in women’s health. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast growing international markets. Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 9,500 employees with headquarters located in Jersey City, New Jersey. For more information, visit http://www.organon.com and connect with us on LinkedIn and Instagram.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Organon makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Elenice
Senior decision-maker at this company
••••••••@••••••••

See Elenice's verified email →

Stefan
Senior decision-maker at this company
••••••••@••••••••

See Stefan's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Organon's next move

Learn about Strategic plan

Frequently asked

Who acquired Sun Pharmaceutical Industries Ltd?

Sun Pharmaceutical Industries Ltd was acquired by Organon, based in Jersey City. The deal was reported on October 30, 2026. Organon is a global healthcare company formed through a spin-off from Merck, (NYSE: MRK) known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. Organon is publicly traded (OGN) and operates in Biotechnology.

When did Organon acquire Sun Pharmaceutical Industries Ltd?

Organon's acquisition of Sun Pharmaceutical Industries Ltd was reported on October 30, 2026. Organon & Co. has announced a pending merger with Sun Pharmaceutical Industries Limited. This strategic move aligns with Organon's commitment to enhancing women's health and expanding its product offerings. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Sun Pharmaceutical Industries Ltd do?

Sun Pharmaceutical Industries Ltd. is a multinational pharmaceutical company headquartered in Mumbai, India. It is privately held, operating in Biotechnology.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.